Tofacitinib for the treatment of alopecia areata in preadolescent children

被引：41

作者：

Craiglow, Brittany G. ^{[1
,2
]}

King, Brett A. ^{[2
]}

机构：

[1] Dermatol Phys Connecticut, Farifield, CT USA

[2] Yale Univ, Sch Med, Dept Dermatol, POB 208059, New Haven, CT 06520 USA

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2019年 / 80卷 / 02期

关键词：

D O I：

10.1016/j.jaad.2018.08.041

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

[No abstract available]

引用

收藏

页码：568 / 570

页数：4

相关论文

共 5 条

[1] Topical Janus kinase inhibitors for the treatment of pediatric alopecia areata [J].

Bayart, Cheryl B. ;

DeNiro, Katherine L. ;

Brichta, Lars ;

Craiglow, Brittany G. ;

Sidbury, Robert .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 77 (01) :167-170

[2] Experience with oral tofacitinib in 8 adolescent patients with alopecia universalis [J].

Castelo-Soccio, Leslie .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (04) :754-755

[3] Tofacitinib for the treatment of alopecia areata and variants in adolescents [J].

Craiglow, Brittany G. ;

Liu, Lucy Y. ;

King, Brett A. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (01) :29-32

[4] Alopecia areata is associated with impaired health-related quality of life: A survey of affected adults and children and their families [J].

Liu, Lucy Y. ;

King, Brett A. ;

Craiglow, Brittany G. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) :556-558

[5] Topical 2% tofacitinib for children with alopecia areata, alopecia totalis, and alopecia universalis [J].

Putterman, Elana ;

Castelo-Soccio, Leslie .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 78 (06) :1207-+